A phase II study of anlotinib plus whole brain radiation therapy (WBRT) for advanced non-small cell lung cancer with multiple brain metastases.

Xiangzhi Zhu,Hua Tao,Ming Jiang,Meiqi Shi,Cheng Kong,Xue Song,Nan Zhang,Cheng Chen,Ning Jiang,LiJun Zhao,Pengwei Yan,Xia He

A phase II study of anlotinib plus whole brain radiation therapy (WBRT) for advanced non-small cell lung cancer with multiple brain metastases.

2021

Xiangzhi Zhu
Hua Tao
Ming Jiang
Meiqi Shi
Cheng Kong
Xue Song
Nan Zhang
Cheng Chen
Ning Jiang
LiJun Zhao
Pengwei Yan
Xia He

e21063Background: The prognosis of non-small-cell lung cancer (NSCLC) patients(pts) with multiple brain metastases is poor. WBRT is the main treatment for the pts, but QUARTZ study showed that the ...

Keywords:

Medicine
non small cell
Lung cancer
Internal medicine
Phases of clinical research
Oncology
Whole brain radiation therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations